Search for: "Merck v. State"
Results 41 - 60
of 710
Sort by Relevance
|
Sort by Date
7 Mar 2022, 12:44 am
Case Background: Merck v ClonmelThe Irish case related to Merck's SPC for its combination product INEGY, which contains the active ingredients ezetimibe and simvastatin. [read post]
12 Feb 2022, 5:42 am
(b)(1); DuPont Merck Pharmaceutical Co. v. [read post]
4 Feb 2022, 1:54 pm
TrustID, Inc. v. [read post]
20 Jan 2022, 8:57 pm
The FDA and state and local regulatory officials traced the romaine lettuce to 23 farms and 36 fields in the Yuma growing region. [read post]
13 Jan 2022, 6:15 am
Merck & Co. [read post]
5 Jan 2022, 4:33 am
Daubert v. [read post]
13 Dec 2021, 12:49 am
However, in a decision of the Irish Court of Appeal in Merck v Clonmel [2021] IECA 54, an SPC for a combination product INEGY (ezetimibe and simvastatin) was found not to contravene Article 3(d). [read post]
7 Dec 2021, 2:01 am
Julie Gerberding, who served as director of the Centers for Disease Control and Prevention from 2002 to 2009 and now is a senior leader at the pharmaceutical company Merck; and Matt Berrett, a former CIA assistant director and head of its Global Issues Mission Center, and now cofounder of the Center for Anticipatory Intelligence at Utah State University. [read post]
19 Nov 2021, 10:46 am
Neurelis argued that the exemption to the anti-SLAPP law was specifically focused on overturning DuPont Merck Pharmaceutical Co. v. [read post]
18 Sep 2021, 2:28 pm
The lack of express terms within the statute is significant: even "broad rulemaking power must be exercised within the bounds set by Congress," Merck & Co. v. [read post]
3 Sep 2021, 10:21 am
Children’s Health Defense v. [read post]
13 Aug 2021, 9:30 pm
RIP, Stephen L Wasby (University of Albany-SUNY).ICYMI: Ashton Merck on Richard Nixon, Robert H. [read post]
Foreign Judgments: The Limits of Transnational Issue Estoppel, Reciprocity, and Transnational Comity
26 May 2021, 8:40 pm
Written by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University In Merck Sharp & Dohme Corp v Merck KGaA [2021] SGCA 14, a full bench of the Singapore Court of Appeal addressed the limits of transnational issue estoppel in Singapore law, and flagged possible fundamental changes to the common law on the recognition and enforcement of foreign judgments in Singapore. [read post]
13 May 2021, 2:24 pm
Class action tolling was critically important for investors for many reasons, including because most securities class actions do not reach a court decision on class certification until after the repose period has expired (or substantially expired), and the class action tolling doctrine serves one of the class action device’s raisons d’être—concentrating like claims in a single representative proceeding and avoiding splintered litigation and a morass of protective filings.[4]… [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
12 Jan 2021, 12:19 pm
In this case growing out of underlying German Merck v. [read post]
8 Dec 2020, 1:00 pm
[1] Complaint at 1-2, Merck Sharp & Dohme Corp. v. [read post]
